3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
7
Uterine Cervical Neoplasms
5
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Retinoblastoma
1
Radiation Injuries
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Genital Neoplasms, Female
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Surveys and Questionnaires
5
Blood Specimen Collection
2
ulipristal acetate
1
relugolix
1
Vaginal Smears
1
Ultrasound, High-Intensity Focused, Transrectal
1
Tablets
1
Sutures
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radionuclide Imaging
1
Radio
1
Quality of Life
1
Patient Reported Outcome Measures
1
Papanicolaou Test
1
Molecular Diagnostic Techniques
1
Mitomycin
1
Lymph Node Excision
1
Liquid Biopsy
1
Laparoscopy
1
Immunotherapy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Health
1
Genetic Profile
1
Drug Therapy
1
Doxorubicin
1
Cisplatin
1
Brachytherapy
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Uterine Neoplasms
×
Brachytherapy
×
Clear all
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled